MedPath

BRINEURA

BRINEURA

Approved
DIN Number

02484013

Drug Class

Human

Market Date

Mar 18, 2019

Company
HC

Biomarin International Limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02484013
AIG Number0161050001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
A16AB17 CERLIPONASE ALFA
Product Specifications
Dosage FormSolution
Route of AdministrationIntracerebroventricular
AHFS Classification44:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

CERLIPONASE ALFAActive
Strength: 150 MG / 5 ML
Monograph: CERLIPONASE ALFA

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.